BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7500546)

  • 21. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow.
    Caputo L; Tedgui A; Lévy BI
    Circ Res; 1995 Aug; 77(2):303-9. PubMed ID: 7614717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat.
    Kohara K; Mikami H; Okuda N; Higaki J; Ogihara T
    Hypertension; 1993 Jun; 21(6 Pt 2):975-9. PubMed ID: 8505110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat.
    Kaneko K; Susic D; Nunez E; Frohlich ED
    J Hypertens; 1996 May; 14(5):645-53. PubMed ID: 8762209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
    Nishikimi T; Tani T; Ohmura T; Yamagishi H; Yanagi S; Yoshiyama M; Toda I; Teragaki M; Akioka K; Takeuchi K
    Jpn Circ J; 1995 Nov; 59(11):754-61. PubMed ID: 8747765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II antagonism and pre-glomerular arterial wall dimensions in the kidney of the spontaneously hypertensive rat.
    Anderson WP; Kett MM; Alcorn D; Bertram JF
    Clin Exp Hypertens; 1997; 19(5-6):965-79. PubMed ID: 9247768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
    Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of chronic inhibition of calcium channel and angiotensin II type 1-receptor on aldosterone synthesis in spontaneously hypertensive rats.
    Otsuka F; Ogura T; Kataoka H; Kishida M; Takahashi M; Mimura Y; Yamauchi T; Makino H
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):125-36. PubMed ID: 11086231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
    Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E; Hosoya K; Susic D; Frohlich ED
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries.
    Shaw LM; George PR; Oldham AA; Heagerty AM
    J Hypertens; 1995 Oct; 13(10):1135-43. PubMed ID: 8586805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
    Kumagai H; Averill DB; Khosla MC; Ferrario CM
    Hypertension; 1993 Apr; 21(4):476-84. PubMed ID: 8384603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD; Thibault G; Li JS; Schiffrin EL
    Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.